Facilitating Optimal Routines in Aging
Completed · Not applicable
Conditions studied: Mild Cognitive Impairment
In brief
Loss of cognitive abilities leading to Alzheimer's disease is progressive and destructive, leaving older adults disabled and unable to recall their past. The number of older adults with Alzheimer's disease is expected to triple by the year 2050, yet little research examines amyloid beta deposition, executive function, and progression of disability. This study will test the influence of a novel and promising non-pharmacological intervention, Strategy Training, on the progression of disability in a sample of 150 older adults with Mild Cognitive Impairment who have the option to complete a Positron Emission Tomography (PET) Imaging with Pittsburgh Compound B (PiB).
Key facts
- Study ID
- NCT03913637
- Run by
- University of Pittsburgh
- People needed
- 105
- Starts
- 2019-07-31
- Expected to finish
- 2025-11-30
- Last updated by the study team
- 2026-03-04
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of Mild Cognitive Impairment
- Acknowledge difficulty with a daily activity
- Community dwelling
You may not qualify if…
- Pregnant
- Central Nervous System disorder (other than MCI)
- Substance disorder in past 5 years
- Lifetime history of bipolar disorder, schizophrenia, or deemed unsafe to proceed in the study (e.g., untreated Major Depressive Disorder)
- Severe medical condition that limits engagement in daily activities
Where it is running
- University of Pittsburgh — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.